Pharmaceutical News

RSS

Cardiome signs deal with VIANEX to commercialize and distribute BRINAVESS in Greece

Cardiome Pharma Corp. today announced that Cardiome International A.G., a subsidiary of Cardiome Pharma Corp., has entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESS™ (vernakalant IV) in Greece.

28 Mar 2014

Seroxat in combination with acupuncture produces significant effect in patients with unipolar depression

Acupuncture is more effective than oral antidepressants in improving depressive symptoms, and produces fewer side effects than tricyclic antidepressants.

28 Mar 2014

Antidepressant medications during pregnancy linked with increased rates of preterm birth

Antidepressant medications taken by pregnant women are associated with increased rates of preterm birth. This finding reinforces the notion that antidepressants should not be used by pregnant women in the absence of a clear need that cannot be met through alternative approaches, say researchers from Brigham and Women's Hospital, Vanderbilt University, MetroWest Medical Center, and Tufts Medical Center.

28 Mar 2014

Guidelines for treating paracetamol overdoses cost millions of pounds per year, say researchers

Strict guidelines for treating paracetamol overdoses - introduced 18 months ago - are costing the NHS millions of pounds a year, researchers claim.

27 Mar 2014

FDA accepts AVP-825 NDA for acute treatment of migraine

The U.S. Food and Drug Administration has accepted the New Drug Application (NDA) for AVP-825, an innovative closed-palate Breath Powered investigational drug-device combination product for the acute treatment of migraine.

27 Mar 2014

New drug multiplies analgesic effect of opioids without increasing constipation

Scientists from the University of Granada have taken part, alongside the Esteve laboratory, in the development of a new drug that multiplies the analgesic effect of opioids (drugs for treating intense pain), without increasing constipation, one of the most common side-effects of these drugs, among which is morphine.

27 Mar 2014

Jury returns verdict in favor of Mylan in breach of contract case against GSK

Mylan Inc. today announced that, after a trial in the United States District Court for the District of New Jersey, a jury returned a verdict in favor of Mylan in its breach of contract lawsuit against GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride Extended-release (ER) Tablets.

27 Mar 2014

PrescribeWellness and APhA Foundation join forces to provide community pharmacies

At the American Pharmacists Association (APhA) Convention here today, PrescribeWellness announced a partnership with the APhA Foundation to provide community pharmacies new tools to help their diabetic patients improve their disease management and health.

27 Mar 2014

Biodelivery Sciences collaborates with Quintiles to launch BUNAVAIL in the U.S.

BioDelivery Sciences International, Inc. announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated launch of BUNAVAIL (buprenorphine and naloxone buccal film), BDSI's proposed maintenance treatment for opioid dependence.

27 Mar 2014

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Updated Phase 1/2a results with GEN-003, a vaccine candidate under development by Genocea Biosciences, Inc. (Nasdaq: GNCA) for the treatment of herpes simplex virus type 2 (HSV-2) infection, showed the experimental vaccine to generate highly significant reductions in both the number of clinical lesion days and rate of viral shedding at six months after the final vaccine dose.

27 Mar 2014

Research points strong reason to develop new class of antidepressant drug

Scientists have shown for the first time that a chemical in the brain called galanin is involved in the risk of developing depression.

From The University of Manchester 27 Mar 2014

New era of lung cancer therapy close to dawning

A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.

27 Mar 2014

Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

Dr. Reddy's Laboratories announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration.

27 Mar 2014

Genetic testing could help determine drug dosage, reduce side effects

Usually pharmaceutical companies determine the drug dosage just as a mean value. This amount may be too much for patients who absorb the substance faster, and too little for those with a slower metabolism.

27 Mar 2014

Mephedrone drug causes acute withdrawal symptoms, shows study

Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy.

27 Mar 2014

Surveys show drug safety budgets grew between 2012 and 2013, estimated to increase in 2014

Recent surveys by Cutting Edge Information found that the majority of drug safety budgets grew between 2012 and 2013, and are projected to continue growth for 2014.

26 Mar 2014

Low dose injections of artificial properdin provides protection against septic diseases in mice

Breakthrough MRC-funded study from University of Leicester shows low dose injections of artificial properdin provides substantial protection against septic diseases in mice

26 Mar 2014

United Therapeutics' Remodulin Injection gets approval in Japan for PAH treatment

United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.

26 Mar 2014

Oral cancer drug improves outcomes in women with resistant gynecologic cancers

An oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.

26 Mar 2014

Inovio Pharmaceuticals receives three industry awards at World Vaccine Congress

Inovio Pharmaceuticals, Inc. today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders.

26 Mar 2014

Pharmaceutical News

Cardiome signs deal with VIANEX to commercialize and distribute BRINAVESS in Greece

Seroxat in combination with acupuncture produces significant effect in patients with unipolar depression

Antidepressant medications during pregnancy linked with increased rates of preterm birth

Guidelines for treating paracetamol overdoses cost millions of pounds per year, say researchers

FDA accepts AVP-825 NDA for acute treatment of migraine

New drug multiplies analgesic effect of opioids without increasing constipation

Jury returns verdict in favor of Mylan in breach of contract case against GSK

PrescribeWellness and APhA Foundation join forces to provide community pharmacies

Biodelivery Sciences collaborates with Quintiles to launch BUNAVAIL in the U.S.

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Research points strong reason to develop new class of antidepressant drug

New era of lung cancer therapy close to dawning

Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets

Genetic testing could help determine drug dosage, reduce side effects

Mephedrone drug causes acute withdrawal symptoms, shows study

Surveys show drug safety budgets grew between 2012 and 2013, estimated to increase in 2014

Low dose injections of artificial properdin provides protection against septic diseases in mice

United Therapeutics' Remodulin Injection gets approval in Japan for PAH treatment

Oral cancer drug improves outcomes in women with resistant gynecologic cancers

Inovio Pharmaceuticals receives three industry awards at World Vaccine Congress

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News